Saxagliptin hydrate 25 mg | 99.80%
TargetMol
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
More Information Supplier PageSaxagliptin hydrate
Search Results
Saxagliptin hydrate 50 mg | 99.80%
TargetMol
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
More Information Supplier PageSaxagliptin hydrate
Saxagliptin hydrate 5 mg | 99.80%
TargetMol
Saxagliptin is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).
More Information Supplier PageSaxagliptin hydrate
Ticagrelor 100 mg | 100.00%
TargetMol
Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and […]
More Information Supplier PageTicagrelor
Ticagrelor 25 mg | 100.00%
TargetMol
Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and […]
More Information Supplier PageTicagrelor
Amorolfine hydrochloride 100 mg | Purity Not Available
TargetMol
Amorolfine Hydrochloride is an antifungal reagent. It exerts the antifungal activity by selectively interrupting two steps in the pathway of ergosterol synthesis and eventually disrupting the function and structure of fungal cell membrane. Amorolfine, a morpholine antifungal drug, can inhibit D14 reductase and D7-D8 isomerase. These enzymes can deplete ergosterol and cause ignosterol to accumulate […]
More Information Supplier PageAmorolfine hydrochloride 200 mg | Purity Not Available
TargetMol
Amorolfine Hydrochloride is an antifungal reagent. It exerts the antifungal activity by selectively interrupting two steps in the pathway of ergosterol synthesis and eventually disrupting the function and structure of fungal cell membrane. Amorolfine, a morpholine antifungal drug, can inhibit D14 reductase and D7-D8 isomerase. These enzymes can deplete ergosterol and cause ignosterol to accumulate […]
More Information Supplier PageOxaliplatin 100 mg | 99.93%
TargetMol
Oxaliplatin
Anagrelide 50 mg | 100.00%
TargetMol
Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production.
More Information Supplier PageAnagrelide
Anagrelide 25 mg | 100.00%
TargetMol
Anagrelide is a Platelet-reducing Agent. The mechanism of action of anagrelide is as a Phosphodiesterase 3 Inhibitor. The physiologic effect of anagrelide is by means of Decreased Platelet Production.
More Information Supplier PageAnagrelide